Calumet Coach of Calumet City, IL, created a European subsidiaryin March 1990 to capitalize on emerging demand for mobile imagingoverseas. Calumet Coach PLC, based near London in Camberly, beganshipping specially designed 12.8-meter mobile imaging vans
Calumet Coach of Calumet City, IL, created a European subsidiaryin March 1990 to capitalize on emerging demand for mobile imagingoverseas. Calumet Coach PLC, based near London in Camberly, beganshipping specially designed 12.8-meter mobile imaging vans inApril of last year, said J. Daniel Snyder, president.
Demand for mobile services in Europe is considerably lessthan that found in the U.S., but the idea appears to be catchingon, he said.
"People have to understand how to make mobile (imaging)work both medically and economically. We are starting to see moreentrepreneurs in many countries (of Europe), but this is stillin the early stages," Snyder said. "The whole concept--especiallythat of mobile MRI--has only been discussed for a short time."
As European countries privatize their economies and health-caresystems, obstacles to entrepreneurial shared service are falling.Cultural and regulatory differences between national markets continueto be complicating factors, however, despite the European Communitygoal of market and technical unification by the end of next year.
European imaging vans require more customizing than those soldin the U.S., he said.
"At this point, we have not reached a standard. We arestill dealing with different requirements for different countries.There are so many technologies involved in this (mobile imaging),that it is unrealistic to expect this all to happen in 1992 or1993," Snyder said.
The 12.8-meter length for mobile medical vans, for instance,is an EC standard that is still not fully accepted.
"All of the (EC) countries have not signed up for it yet,but the feeling is that they will," he said.
Calumet Coach has service engineers stationed in England andGermany and plans to increase its facilities on both sides ofthe English Channel. Eventually, the company would like to instituteEuropean manufacturing of vans, he said.
BRIEFLY NOTED:
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.